| Heather Lynn Worth, ARNP | |
|
1001 Pennsylvania Ave, Ottumwa, IA 52501-6427 | |
| (641) 684-2402 | |
| Not Available |
| Full Name | Heather Lynn Worth |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 1001 Pennsylvania Ave, Ottumwa, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134716483 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 107660 (Iowa) | Secondary |
| 363L00000X | Nurse Practitioner | A163422 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ottumwa Regional Health Center | Ottumwa, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ottumwa Health Group Llc | 3971629924 | 27 |
News Archive
FibroGen, Inc., and Astellas Pharma Inc., announced today the initiation of the first clinical study in the Phase 3 clinical development program of FG-4592/ASP1517, an orally administered small molecule, for treatment of anemia associated with chronic kidney disease ("CKD") in patients not on dialysis and on dialysis, to support approval in the U.S. and Europe.
"Around 400 scientists from 80 countries have come together to declare that polio could be wiped off the face of the Earth in five years if plans to eliminate both wild and vaccine-derived polioviruses are implemented," SciDev.Net reports (Malhotra, 4/11).
Researchers report today that regions of the human genome have been hotspots for acquiring duplicated DNA sequences - but only at specific time-points during evolution.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
New research suggests that mothers who experience migraine may be more likely to have a baby with colic than mothers without a history of migraine. Colic is defined as excessive crying in an otherwise healthy infant. The research was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.
› Verified 7 days ago
| Entity Name | Ottumwa Health Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386956290 PECOS PAC ID: 3971629924 Enrollment ID: O20100927001257 |
News Archive
FibroGen, Inc., and Astellas Pharma Inc., announced today the initiation of the first clinical study in the Phase 3 clinical development program of FG-4592/ASP1517, an orally administered small molecule, for treatment of anemia associated with chronic kidney disease ("CKD") in patients not on dialysis and on dialysis, to support approval in the U.S. and Europe.
"Around 400 scientists from 80 countries have come together to declare that polio could be wiped off the face of the Earth in five years if plans to eliminate both wild and vaccine-derived polioviruses are implemented," SciDev.Net reports (Malhotra, 4/11).
Researchers report today that regions of the human genome have been hotspots for acquiring duplicated DNA sequences - but only at specific time-points during evolution.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
New research suggests that mothers who experience migraine may be more likely to have a baby with colic than mothers without a history of migraine. Colic is defined as excessive crying in an otherwise healthy infant. The research was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.
› Verified 7 days ago
| Entity Name | Des Moines River Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720472442 PECOS PAC ID: 0143549634 Enrollment ID: O20150505001794 |
News Archive
FibroGen, Inc., and Astellas Pharma Inc., announced today the initiation of the first clinical study in the Phase 3 clinical development program of FG-4592/ASP1517, an orally administered small molecule, for treatment of anemia associated with chronic kidney disease ("CKD") in patients not on dialysis and on dialysis, to support approval in the U.S. and Europe.
"Around 400 scientists from 80 countries have come together to declare that polio could be wiped off the face of the Earth in five years if plans to eliminate both wild and vaccine-derived polioviruses are implemented," SciDev.Net reports (Malhotra, 4/11).
Researchers report today that regions of the human genome have been hotspots for acquiring duplicated DNA sequences - but only at specific time-points during evolution.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
New research suggests that mothers who experience migraine may be more likely to have a baby with colic than mothers without a history of migraine. Colic is defined as excessive crying in an otherwise healthy infant. The research was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.
› Verified 7 days ago
| Entity Name | Emergency Services Of Iowa Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477017663 PECOS PAC ID: 1557600756 Enrollment ID: O20190306001336 |
News Archive
FibroGen, Inc., and Astellas Pharma Inc., announced today the initiation of the first clinical study in the Phase 3 clinical development program of FG-4592/ASP1517, an orally administered small molecule, for treatment of anemia associated with chronic kidney disease ("CKD") in patients not on dialysis and on dialysis, to support approval in the U.S. and Europe.
"Around 400 scientists from 80 countries have come together to declare that polio could be wiped off the face of the Earth in five years if plans to eliminate both wild and vaccine-derived polioviruses are implemented," SciDev.Net reports (Malhotra, 4/11).
Researchers report today that regions of the human genome have been hotspots for acquiring duplicated DNA sequences - but only at specific time-points during evolution.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
New research suggests that mothers who experience migraine may be more likely to have a baby with colic than mothers without a history of migraine. Colic is defined as excessive crying in an otherwise healthy infant. The research was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Lynn Worth, ARNP 1673 Bridge St, Albia, IA 52531-8751 Ph: (515) 443-9914 | Heather Lynn Worth, ARNP 1001 Pennsylvania Ave, Ottumwa, IA 52501-6427 Ph: (641) 684-2402 |
News Archive
FibroGen, Inc., and Astellas Pharma Inc., announced today the initiation of the first clinical study in the Phase 3 clinical development program of FG-4592/ASP1517, an orally administered small molecule, for treatment of anemia associated with chronic kidney disease ("CKD") in patients not on dialysis and on dialysis, to support approval in the U.S. and Europe.
"Around 400 scientists from 80 countries have come together to declare that polio could be wiped off the face of the Earth in five years if plans to eliminate both wild and vaccine-derived polioviruses are implemented," SciDev.Net reports (Malhotra, 4/11).
Researchers report today that regions of the human genome have been hotspots for acquiring duplicated DNA sequences - but only at specific time-points during evolution.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
New research suggests that mothers who experience migraine may be more likely to have a baby with colic than mothers without a history of migraine. Colic is defined as excessive crying in an otherwise healthy infant. The research was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.
› Verified 7 days ago
Kimberly Joan Brown, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 522 N Hancock St, Ottumwa, IA 52501 Phone: 641-683-0800 Fax: 641-683-0801 | |
Jennifer Stromgren, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1527 Albia Rd, Ottumwa, IA 52501 Phone: 641-682-8772 | |
Stacy Lynnae Crill, DNP, CPNP-PC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 123 E 3rd St, Ottumwa, IA 52501 Phone: 641-682-8145 Fax: 641-682-8857 | |
Mrs. Jayci Michelle Beamer, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1009 Pennsylvania Ave, Ottumwa, IA 52501 Phone: 641-683-4300 | |
Ashley Bland, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 522 N Hancock St, Ottumwa, IA 52501 Phone: 641-683-0800 Fax: 641-683-0801 | |
Jamie Lee Hyde, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1001 Pennsylvania Ave, Ottumwa, IA 52501 Phone: 641-682-7511 Fax: 641-684-2324 | |
Deborah L Stephenson, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 522 N Hancock St, Ottumwa, IA 52501 Phone: 641-682-4594 Fax: 641-682-2123 |